Quantbot Technologies LP Supernus Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

$3.55 Billion
Q2 2025

A detailed history of Quantbot Technologies LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 18,566 shares of SUPN stock, worth $957,819. This represents 0.02% of its overall portfolio holdings.

Number of Shares

18,566

Previous 3,150 489.4%

Holding current value

$957,819

Previous $103,000 467.96%

% of portfolio

0.02%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$30.29 - $33.43 $466,950 - $515,356	15,416 Added 489.4%	18,566 $585,000
Q1 2025 May 13, 2025	BUY	$31.17 - $40.0 $98,185 - $126,000	3,150 New	3,150 $103,000
Q3 2024 Nov 13, 2024	SELL	$25.77 - $35.16 $556,657 - $759,491	-21,601 Reduced 95.47%	1,026 $31,000
Q2 2024 Aug 09, 2024	BUY	$25.99 - $33.85 $588,075 - $765,923	22,627 New	22,627 $605,000
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $152,246 - $198,885	6,701 New	6,701 $193,000
Q2 2023 Aug 08, 2023	BUY	$29.91 - $38.73 $99,630 - $129,009	3,331 New	3,331 $100,000
Q4 2022 Feb 13, 2023	SELL	$31.09 - $37.88 $36,002 - $43,865	-1,158 Reduced 68.56%	531 $18,000
Q3 2022 Nov 07, 2022	BUY	$28.79 - $35.41 $48,626 - $59,807	1,689 New	1,689 $57,000
Q4 2021 Feb 11, 2022	SELL	$26.37 - $34.22 $163,045 - $211,582	-6,183 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$23.54 - $31.39 $145,547 - $194,084	6,183 New	6,183 $164,000
Q2 2021 Aug 12, 2021	SELL	$26.72 - $33.19 $46,252 - $57,451	-1,731 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.15 - $31.45 $41,803 - $54,439	1,731 New	1,731 $45,000
Q2 2019 Aug 13, 2019	SELL	$29.96 - $38.87 $166,637 - $216,194	-5,562 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$32.77 - $41.99 $4,522 - $5,794	-138 Reduced 2.42%	5,562 $194,000
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $106,336 - $170,710	3,448 Added 153.11%	5,700 $189,000
Q3 2018 Nov 13, 2018	BUY	$42.7 - $56.55 $96,160 - $127,350	2,252 New	2,252 $113,000
Q2 2018 Aug 13, 2018	SELL	$44.1 - $59.85 $97,549 - $132,388	-2,212 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$37.15 - $46.9 $192,474 - $242,988	-5,181 Reduced 70.08%	2,212 $101,000
Q4 2017 Feb 12, 2018	BUY	$36.4 - $42.6 $43,134 - $50,481	1,185 Added 19.09%	7,393 $294,000
Q3 2017 Nov 07, 2017	BUY	$36.75 - $49.65 $228,144 - $308,227	6,208	6,208 $248,000

Others Institutions Holding SUPN

# of Institutions

313

Shares Held

61.5M

Call Options Held

18.4K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.76B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Supernus Pharmaceuticals, Inc. Transaction History